FDA Inspection
Ipsen BioPharm LtdIpsen BioPharm Ltd – FDA Inspection, May 22, 2025
Record Details
This FDA Inspection record concerns Ipsen BioPharm Ltd, with an inspection on May 22, 2025, issued by the Center for Drug Evaluation and Research, covering drugs.
- Company
- Ipsen BioPharm Ltd
- Inspection Date
- May 22, 2025
- Product Type
- Drugs
View Company Profile
ID · 896e1ea1-ceca-49a8-b29d-2432591f8ae9
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 1283174
- FDA center
- Human Drugs
- Project area
- Drug Quality Assurance
Other FDA inspections of Ipsen BioPharm Ltd
7| Date | Classification | Office | Project area |
|---|---|---|---|
| April 26, 2019 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| July 6, 2018 | VAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
| September 12, 2017 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| January 20, 2016 | VAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
| July 8, 2014 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
Other documents for Ipsen BioPharm Ltd
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.